Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP646053.RAcj6WPJ7VOcCJ4OH8_2ey16Xd30SmmIM6RQH3i3fbsSY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP646053.RAcj6WPJ7VOcCJ4OH8_2ey16Xd30SmmIM6RQH3i3fbsSY130_assertion type Assertion NP646053.RAcj6WPJ7VOcCJ4OH8_2ey16Xd30SmmIM6RQH3i3fbsSY130_head.
- NP646053.RAcj6WPJ7VOcCJ4OH8_2ey16Xd30SmmIM6RQH3i3fbsSY130_assertion description "[The dysregulation of the RAS/MAPK pathway appears to be a common molecular pathogenesis of these disorders: mutations in PTPN11, KRAS, and SOS1 have been identified in patients with NS, those in KRAS, BRAF, MAP2K1, and MAP2K2 in patients with CFC syndrome, and those in HRAS mutations in Costello syndrome patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646053.RAcj6WPJ7VOcCJ4OH8_2ey16Xd30SmmIM6RQH3i3fbsSY130_provenance.
- NP646053.RAcj6WPJ7VOcCJ4OH8_2ey16Xd30SmmIM6RQH3i3fbsSY130_assertion evidence source_evidence_literature NP646053.RAcj6WPJ7VOcCJ4OH8_2ey16Xd30SmmIM6RQH3i3fbsSY130_provenance.
- NP646053.RAcj6WPJ7VOcCJ4OH8_2ey16Xd30SmmIM6RQH3i3fbsSY130_assertion SIO_000772 20052757 NP646053.RAcj6WPJ7VOcCJ4OH8_2ey16Xd30SmmIM6RQH3i3fbsSY130_provenance.
- NP646053.RAcj6WPJ7VOcCJ4OH8_2ey16Xd30SmmIM6RQH3i3fbsSY130_assertion wasDerivedFrom befree-20150227 NP646053.RAcj6WPJ7VOcCJ4OH8_2ey16Xd30SmmIM6RQH3i3fbsSY130_provenance.
- NP646053.RAcj6WPJ7VOcCJ4OH8_2ey16Xd30SmmIM6RQH3i3fbsSY130_assertion wasGeneratedBy ECO_0000203 NP646053.RAcj6WPJ7VOcCJ4OH8_2ey16Xd30SmmIM6RQH3i3fbsSY130_provenance.